Aufrufe
vor 3 Monaten

Life Sciences Report 2017 / 2018

  • Text
  • Technology
  • Medicine
  • Pharma
  • Berlin
  • Innovative
  • Clinical
  • Sciences
  • Solutions
  • Pharmaceutical
  • Biotech
  • Diagnostics

10 Life

10 Life Sciences Report – Excellent Conditions for Transfer and Translation Excellent Conditions for Transfer and Translation For many companies that have come to the German capital region or were founded here, the outstanding academic and scientific landscape is a decisive factor for success. Scientists conduct excellent life sciences research here, characterized by a broad spectrum and close interdisciplinary networking. The region features short paths to exchanges and partnerships – not only between different research institutions, but also between industry, clinics, and academic research in various ways. Important elements are transfer-oriented platforms, networks, and technology parks. The German capital region is home to over 40 renowned scientific institutions, including the Charité – Universitätsmedizin Berlin, the Robert Koch Institute, the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), the German Heart Center Berlin, and other well-known Fraunhofer, Helmholtz, Leibniz and Max Planck Institutes. The Charité is one of the largest university hospitals in Europe. More than 4,500 physicians and scientists carry out research, teach, and treat patients here at the cutting edge of international medicine. The Berlin Institute of Health (BIH) will be the new flagship of world-class research institutions. Scientists from Charité and MDC have been carrying out research together at BIH since 2013. BIH is a scientific institution for translational research and systems medicine and is being established as a unique structure in Germany’s biomedical research landscape. The BIH, the Charité, the MDC and Sanofi, Germany GmbH signed a joint research framework agreement in Berlin on October 4, 2017. In the future, the institutions will work together closely on the development of novel therapies for various diseases. In addition, the partners will support talented young researchers and projects with economic and medical potential. To launch innovative products and processes into the market, innovative structures and programs that facilitate and accelerate the technology transfer along the entire value chain are required. For translational research and the interdisciplinary transfer of knowledge between researchers, for close networks between science and business, and the exchange between creative minds on the one side and financial backers on the other – in the German capital region, there are transfer and translation centers for a variety of topics and technologies, such as the Berlin- Brandenburg Center for Regenerative Therapies BCRT (see Regenerative Medicine chapter), the Experimental and Clinical Research Center ECRC (see Medical Imaging chapter), or the screening unit at the FMP (see highlight). Technology parks: next door to the medicine of the future Industry, science, clinical care providers – ideally in close proximity and partnership with each other. This way, ideas can best be advanced to tomorrow’s top technologies and services and be patient-oriented. Berlin-Brandenburg offers exactly this and is characterized by excellent infrastructures, which provide straightforward services and make efficient networks possible. For example, there are eight technology parks in the region that are active in the life sciences, among others. These include Germany’s largest Biotech Park Berlin-Buch, Europe’s leading technology park Berlin- David Ausserhofer © 2008 “The Berlin Institute of Health explores disruptive aspects of health care, from personalized and digital medicine to novel cellular therapies, through long-term translational programs and research platforms. In doing so, we’re not only forming a bridge between basic research and clinical research, but also to development in industry, right up to the patient.” Dr. Rolf Zettl Chief Financial Officer and Member of the Executive Board, Berlin Institute of Health (BIH)

Life Sciences Report – Excellent Conditions for Transfer and Translation 11 © Peter Himsel/BBB Management GmbH The laboratory building for medical genome research on the Berlin-Buch campus. Adlershof, and GO:IN at the renowned Potsdam-Golm science center (see all parks on page 52). Campus Berlin-Buch, known for its top research institutes and biotechnology companies, is one of Germany’s largest biomedical centers. The health care sector in the Health Location Berlin-Buch provides more than 6,000 jobs, of which nearly 2,100 are in basic and clinical research facilities. The Berlin-Buch Biotech Park with its approx. 31,000 m² is one of the leading technology parks in Germany and is located in close proximity to institutions such as the MDC, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), and companies such as the global player Eckert & Ziegler. At the other end of the city – in the south of Berlin – Europe’s leading technology park is located on an area that is 4.2 km² in size. With approximately 1,000 technology-oriented companies, 16 scientific institutions, two start-up centers, over 16,000 employees, and around 6,700 students, Berlin Adlershof is the largest science and technology center in Germany. GO:IN at the Golm site in Potsdam offers excellent spatial conditions for start-ups or small and medium-sized companies from research and development as well as an excellent, inspiring scientific environment. Next door to the scientific disciplines and institutes of the University of Potsdam and embedded in the largest science park in the Federal State of Brandenburg, GO:IN is a center for the development and marketing of scientific knowledge. In addition to state-of-the-art and functional laboratory and office spaces, the focus here is on the founding spirit and an enthusiasm for new beginnings, Thanks to the many cooperating research groups, Berlin is one of the best locations for neuroscientists. I love the open atmosphere here. www.braincity.berlin Dr. Tatiana Korotkova Behavioral Neurodynamics Leibniz-Institut für Molekulare Pharmakologie (FMP) NeuroCure Cluster of Excellence Campus Charité Mitte © Berlin Partner, Photography: Philipp Jester

Publications in English

Publikationen auf deutsch

Clusterreport Verkehr, Mobilität und Logistik
Schienenverkehrstechnik
Verkehrstelematik
Logistik
Automotive in der Hauptstadtregion Berlin-Brandenburg
Aerospace Industrie
Biotech- und Pharmaindustrie
Forschung für die Gesundheit
Gesundheitsversorgung und Prävention
Potenzialstudie Medizintourismus Berlin-Brandenburg_2015
Clusterbroschuere Gesundheitswirtschaft
Prävention und Gesundheitsförderung
Rehabilitation in Berlin und Brandenburg
Games Industrie in der Hauptstadtregion Berlin-Brandenburg
Digitale Wirtschaft in Berlin
Fernsehen in der Hauptstadtregion Berlin-Brandenburg
Fashion in Berlin
Best Practice Wireless in der Hauptstadtregion Berlin-Brandenburg
Medien und Kreativwirtschaft in Berlin-Brandenburg
Turbomaschinen und Kraftwerkstechnik
Energienetze und -speicher in der Hauptstadtregion Berlin-Brandenburg
Kreislaufwirtschaft in Berlin
Wasserwirtschaft in Berlin
Energietechnik in der Hauptstadtregion Berlin-Brandenburg
Service Packages für Unternehmen in Berlin
Unternehmensservice in den Berliner Bezirken
Berlin Partner: Unser Service fuer Sie